Martin Clair R, Osadchiy Vadim, Kalani Amir, Mayer Emeran A
G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, Microbiome Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Cell Mol Gastroenterol Hepatol. 2018 Apr 12;6(2):133-148. doi: 10.1016/j.jcmgh.2018.04.003. eCollection 2018.
Preclinical and clinical studies have shown bidirectional interactions within the brain-gut-microbiome axis. Gut microbes communicate to the central nervous system through at least 3 parallel and interacting channels involving nervous, endocrine, and immune signaling mechanisms. The brain can affect the community structure and function of the gut microbiota through the autonomic nervous system, by modulating regional gut motility, intestinal transit and secretion, and gut permeability, and potentially through the luminal secretion of hormones that directly modulate microbial gene expression. A systems biological model is proposed that posits circular communication loops amid the brain, gut, and gut microbiome, and in which perturbation at any level can propagate dysregulation throughout the circuit. A series of largely preclinical observations implicates alterations in brain-gut-microbiome communication in the pathogenesis and pathophysiology of irritable bowel syndrome, obesity, and several psychiatric and neurologic disorders. Continued research holds the promise of identifying novel therapeutic targets and developing treatment strategies to address some of the most debilitating, costly, and poorly understood diseases.
临床前和临床研究表明,脑-肠-微生物群轴内存在双向相互作用。肠道微生物通过至少3个平行且相互作用的通道与中枢神经系统进行交流,这些通道涉及神经、内分泌和免疫信号机制。大脑可以通过自主神经系统影响肠道微生物群的群落结构和功能,调节局部肠道运动、肠道转运和分泌以及肠道通透性,还可能通过直接调节微生物基因表达的激素的腔内分泌来实现。本文提出了一种系统生物学模型,该模型假定大脑、肠道和肠道微生物群之间存在循环通信回路,并且在该回路中,任何水平的扰动都可能在整个回路中传播失调。一系列主要为临床前的观察结果表明,脑-肠-微生物群通信的改变与肠易激综合征、肥胖症以及几种精神和神经疾病的发病机制和病理生理学有关。持续的研究有望确定新的治疗靶点,并开发治疗策略,以应对一些最使人衰弱、成本高昂且了解甚少的疾病。
Cell Mol Gastroenterol Hepatol. 2018-4-12
Clin Gastroenterol Hepatol. 2018-10-4
Am J Physiol Gastrointest Liver Physiol. 2017-4-1
Cell Mol Gastroenterol Hepatol. 2024
J Physiol Pharmacol. 2011-12
Gut Microbes. 2016-9-2
Diabetes Metab Syndr Obes. 2025-8-24
Eat Weight Disord. 2025-9-2
Front Microbiol. 2025-8-13
Curr Issues Mol Biol. 2025-6-26